Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Health Catalyst, Inc

Stage 4 · Declining · week 2

As of Oct 22, 2026, Health Catalyst is in Stage 4, the downtrend phase, now in week 2 (since Oct 13, 2026). It closed at $1.74, 49.7% below its 52-week high and above its 200-day average, which is falling.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. More about the company

$1.74
+0.00% today
$131M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is HCAT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 15w
S4 17w
S1 14w
S4 71w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 2w → S4 15w → S1 9w → S4 17w → S1 14w → S2 9w → S3 6w → S4 71w → S1 9w → S2 4w → S3 5w → S4 1w current
Total tracked: 165 weeks across 13 stage runs.

HCAT among Health Information Services25th of 41 by relative strength

All 41 →
Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AMWLStage 2 · wk 2597+7.4%
2HNGEStage 2 · wk 2096+19.1%
3BTSGStage 3 · wk 894+9.1%
4NRCStage 3 · wk 493−0.1%
5SOPHStage 2 · wk 2491−12.7%
6HTFLStage 2 · wk 1087+17.0%
7HSTMStage 2 · wk 1777+20.3%
8OMCLStage 4 · wk 1070+12.5%
…25HCATStage 4 · wk 226+1.2%
vs 52W High
-49.7%
$1.00 lo$3.46 hi
49.7% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 2
1w13w26w
Week 2, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
0.2%
200 DMA: $1.74 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.33x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+1.2%
3M
-16.3%
6M
+30.8%
YTD
-23.7%
1Y
-45.3%
Scan Membership
Breakout Watch
Latest: 2024-10-16
5 appearances in last 60 days. First seen: 2020-07-29.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 2 · Vol 0.33x
2026-10-21S4
Wk 2 · Vol 0.15x
2026-10-20S4
Wk 2 · Vol 0.25x
2026-10-19S4
Wk 1 · Vol 0.66x
2026-10-16S4
Wk 1 · Vol 0.27x
2026-10-15S4
Wk 1 · Vol 0.46x
2026-10-14S4
Wk 1 · Vol 0.69x
2026-10-13S43→4
Wk 1 · Vol 1.94x
2026-10-12S3
Wk 5 · Vol 0.53x
2026-10-09S3
Wk 5 · Vol 1.58x
2026-10-08S3
Wk 5 · Vol 0.86x
2026-10-07S3
Wk 5 · Vol 0.37x
Moving averages & range
50 DMA
$1.72
200 DMA
$1.74
52W High
$3.46
52W Low
$1.00
5D Low
$1.71
Resistance levels (recent highs)
20d High
$1.80
60d High
$2.39
120d High
$2.39
250d High
$3.46
Next resistance
+3.4%
to 20d High
ROE
-118.1%
Profit margin -90.6%
Dividend Yield
0.00%
P/B 1.3

Health Catalyst: quick answers

What stage is Health Catalyst in?

As of Oct 22, 2026, Health Catalyst (HCAT) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 13, 2026 and is in week 2. What the four stages mean

Is Health Catalyst in an uptrend?

No. Health Catalyst is in a Stage 4 downtrend. It trades 0.2% above its 200-day average, which is falling.

How far is Health Catalyst from its 52-week high?

Health Catalyst closed at $1.74 on Oct 22, 2026, 49.7% below its 52-week high of $3.46. Its 52-week low is $1.00.

How has Health Catalyst performed over the past year?

As of Oct 22, 2026, Health Catalyst is down 45.3% over the past year and down 23.7% so far in 2026.

Which sector and industry is Health Catalyst in?

Health Catalyst is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.